---
$id: https://graph.org.ai/products/commodity/51372004
$type: Product
source: UNSPSC
code: "51372004"
title: "Butorphanol"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butorphanol

**UNSPSC Code**: 51372004
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid with the molecular formula C21H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QV897JC36D, chemically known as morphinan-3,14-diol, 17-(cyclobutylmethyl)- but generally known as butorphanol, which bears US NIH Compound Identifier 2487. Butorphanol most often comes in base and tartrate forms. European Medicines Agency schedules Butorphanol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06035MIG. The term BUTORPHANOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules butorphanol in its Anatomical Therapeutic Chemical (ATC) Classification. BUTORPHANOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butorphanol under HS 29334990 and SITC 51575. As of Q4 2014, BUTORPHANOL remains the US FDA Preferred Term for this commodity. Butorphanol bears US NLM identifiers UMLS ID C0006491 and NCI Concept Code C61659. SMILES: OC12C3(CCN(C1CC1C3CC(O)CC1)CC1CCC1)CCCC2.

